Avacta Group (AVCT)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

46.50p
   
  • Change Today:
      2.25p
  • 52 Week High: 140.00
  • 52 Week Low: 39.75
  • Currency: UK Pounds
  • Shares Issued: 369.31m
  • Volume: 3,090,174
  • Market Cap: £171.73m
  • RiskGrade: 461
  • Beta: 1.25

Avacta Group appoints new non-executive chair

By Josh White

Date: Thursday 20 Jun 2024

LONDON (ShareCast) - (Sharecast News) - Life science company Avacta Group announced the appointment of Shaun Chilton as its non-executive chairman on Thursday, succeeding Eliot Forster, who was stepping down from the board with immediate effect.
The AIM-traded firm said Chilton, who had served as a non-executive director at Avacta since June last year, would bring more than 30 years of experience in biopharma leadership to the role.

He was previously CEO of global pharmaceutical services company Clinigen Group, leading its sale to Triton Partners in 2022 for around £1.3bn.

He had a strong track record in growing sales and enterprise value in both private and public sectors, with significant board experience, including roles at MAP Patient Access and C7 Health, where he also led a successful sale to a strategic buyer in 2022.

Avacta's board said it had been evolving to support its transition into a clinical stage oncology company, with a focus on advancing the clinical development of its 'preCISION' platform.

Recently, Christina Coughlin, then head of research and development, was appointed as chief executive officer.

Dr Coughlin was previously the CEO of Cytoimmune Therapeutics, and chief medical officer at Tmunity, Rubius, and Immunocore.

The board added that it planned further changes to bolster Avacta's transition to a therapeutics-focused organisation.

"I look forward to working with Shaun in his new role as chairman of the Board and continuing to focus on the key goals and priorities for the company," said chief executive officer Christina Coughlin.

"Shaun is keenly aware of the potential that exists in our oncology pipeline to bring value to patients and shareholders alike and we will work together to deliver on that potential.

"I am grateful to Eliot for his guidance he has provided to Avacta and for his leadership across this transition."

At 1549 BST, shares in Avacta Group were up 9.81% at 43.92p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Avacta Group Market Data

Currency UK Pounds
Share Price 46.50p
Change Today 2.25p
% Change 5.08 %
52 Week High 140.00
52 Week Low 39.75
Volume 3,090,174
Shares Issued 369.31m
Market Cap £171.73m
Beta 1.25
RiskGrade 461

Avacta Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.93% below the market average33.93% below the market average33.93% below the market average33.93% below the market average33.93% below the market average
44% below the sector average44% below the sector average44% below the sector average44% below the sector average44% below the sector average
Price Trend
38.43% below the market average38.43% below the market average38.43% below the market average38.43% below the market average38.43% below the market average
26.53% below the sector average26.53% below the sector average26.53% below the sector average26.53% below the sector average26.53% below the sector average
Income Not Available
Growth
65.50% above the market average65.50% above the market average65.50% above the market average65.50% above the market average65.50% above the market average
82.35% above the sector average82.35% above the sector average82.35% above the sector average82.35% above the sector average82.35% above the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Avacta Group Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:37 100,000 @ 46.61p
16:35 9,401 @ 46.50p
16:35 6,401 @ 46.50p
16:35 2,076 @ 46.50p
16:35 38 @ 46.50p

Avacta Group Key Personnel

CFO Tony Peter Gardiner
CEO Christina Coughlin

Top of Page